In Virtual Reality Pop, Sergey Bludov, SVP of Media and Entertainment at DataArt, discusses practical use cases for augmented reality (AR) and virtual reality (VR) in the music industry.
Making the pension gap visible: it-finanzmagazin.de describes the VR AltersvorsorgeCockpit app, a customer-focused project of German insurers R+V, Union Investment, and Schwäbisch‑Hall. The app was developed in collaboration with DataArt.
In the January edition of the iGaming Business Magazine, Russell Karp, VP of Media and Entertainment at DataArt, examines the European betting model and discovers that there are more barriers to its adoption by the US operators than might at first appear.
In Tabb Forum, Cliff Moyce, Chairman of Advisory Board at DataArt, explores the causes and cures for the massive support overhead in the finance sector. Moyce argues that, while being deemed inevitable by the industry, mounting support expenses are due to poor quality software and substandard development culture.
Global Banking and Finance Review Magazine, features an in-depth discussion of 2019 financial technology trends by Cliff Moyce, Chairman of Advisory Board at DataArt. Moyce emphasizes enhanced process automation, advanced data management methodologies, further implementations of the blockchain, machine learning and deep learning as well as rapid adoption of open banking and fintech.
In an exclusive interview with Information Age, Dmitry Bagrov, Director at DataArt UK, dismantles the fashionable term “digital transformation,” and encourages companies to focus on business goals and the necessary change, as opposed to technology.
In Digital Health Age, Kirill Timofeev, Software Project Manager at DataArt, explains how blockchain networks can empower patients and enable efficient, secure and cost-effective sharing of electronic health records.
In Krankenhaus, Vladimir Timashov, Delivery Manager in Healthcare & Life Sciences at DataArt, contributes a bylined article on his experience at the world’s leading medical trade fair – MEDICA, including the panel discussion with Atlantic Therapeutics.